Carregant...
Successful thrombolysis for acute ischaemic stroke after reversal of dabigatran etexilate with idarucizumab
We report the experience of reversing dabigatran prior to administering systemic thrombolysis for acute ischaemic cerebellar stroke, which was well tolerated with no haemorrhagic complications after thrombolysis. Given the increasingly common use of dabigatran for atrial fibrillation, the use of ida...
Guardat en:
| Publicat a: | BMJ Case Rep |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6506077/ https://ncbi.nlm.nih.gov/pubmed/31061182 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-229128 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|